Back to Search
Start Over
LUNESTA Phase III/IV Data to Be Presented at Associated Professional Sleep Societies Annual Meeting
- Source :
- Business Wire. June 15, 2005
- Publication Year :
- 2005
-
Abstract
- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that Phase III/IV clinical data for LUNESTA(TM) brand eszopiclone for the treatment of insomnia will be presented at the Associated Professional [...]
- Subjects :
- Sepracor Inc.
Pharmaceutical industry
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.133242504